Literature DB >> 24815437

Expression of annexin A3 in gastric cancer and its correlation with proliferation and apoptosis.

Jing-Ming Zhai1, Shi-Jun Sun, Wei Wang, Chao Zeng.   

Abstract

Annexin A3 has been identified as a novel biomarker in different types of cancers. However, little is known about its clinical significances and and biological roles in gastric cancer. In this study, we assessed annexin A3 expression in 80 patients with gastric cancer and explore its correlation with prognosis Moreover, correlations with Ki-67, Bcl-2 and Bax were also investigated. Expression of annexin A3 was increased in gastric cancer compared with that in normal gastric tissues. Annexin A3 expression was significantly associated with tumor volume and TNM stage (p<0.05). and inversely correlation with prognosis of patients. More interestingly, expression of annexin A3 was positive correlated with Ki-67 and Bcl-2 expression. Our study showed annexin A3 might be a potential prognostic marker for gastric cancer and involved in tumorigenesis by regulating apoptosis and proliferation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815437     DOI: 10.7314/apjcp.2014.15.7.3001

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

Review 1.  Role of annexin A3 in breast cancer (Review).

Authors:  Alpaslan Ozturk
Journal:  Mol Clin Oncol       Date:  2022-05-12

Review 2.  What gastric cancer proteomic studies show about gastric carcinogenesis?

Authors:  Mariana Ferreira Leal; Fernanda Wisnieski; Carolina de Oliveira Gigek; Leonardo Caires do Santos; Danielle Queiroz Calcagno; Rommel Rodriguez Burbano; Marilia Cardoso Smith
Journal:  Tumour Biol       Date:  2016-04-28

3.  Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.

Authors:  Ying-Fu Liu; Qing-Qing Liu; Yue-Hua Zhang; Jing-Hua Qiu
Journal:  Anal Cell Pathol (Amst)       Date:  2016-11-22       Impact factor: 2.916

4.  Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers.

Authors:  Qian Yang; Michael H Roehrl; Julia Y Wang
Journal:  Oncotarget       Date:  2017-12-22

5.  Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.

Authors:  Ke Wang; Jiansheng Li
Journal:  Oncotarget       Date:  2016-12-27

6.  The footprint of the ageing stroma in older patients with breast cancer.

Authors:  Barbara Brouwers; Debora Fumagalli; Sylvain Brohee; Sigrid Hatse; Olivier Govaere; Giuseppe Floris; Kathleen Van den Eynde; Yacine Bareche; Patrick Schöffski; Ann Smeets; Patrick Neven; Diether Lambrechts; Christos Sotiriou; Hans Wildiers
Journal:  Breast Cancer Res       Date:  2017-07-03       Impact factor: 6.466

7.  ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth.

Authors:  Kunli Du; Jiahui Ren; Zhongxue Fu; Xingye Wu; Jianyong Zheng; Xing Li
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

8.  RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls.

Authors:  Namjoo Kim; Jeong-An Gim; Beom Jae Lee; Byung Il Choi; Seung Bin Park; Hee Sook Yoon; Sang Hee Kang; Seung Han Kim; Moon Kyung Joo; Jong-Jae Park; Chungyeul Kim; Han-Kyeom Kim
Journal:  Funct Integr Genomics       Date:  2021-07-17       Impact factor: 3.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.